Johnson & Johnson’s Robust Growth Signifies Potential Increase in Shareholders Returns?
Johnson & Johnson (NYSE:JNJ) continues accelerating its revenue base through innovations and portfolio diversification. Second-quarter Johnson & Johnson revenue increased at a double-digit rate year over year, driven by a stable performance from Medical Devices …
Biogen Alzheimer’s Drug Trial Sees Positive Results, Shares Soar 20%
Biogen Alzheimer’s Drug Trial: Finding a cure for Alzheimer’s disease can look like an impossible mission, even for the most brilliant minds. What isn’t impossible, however, is offering disease-modifying therapies to those suffering from the …
Is the Dip in Johnson & Johnson Shares Offering a Buying Opportunity?
Johnson & Johnson shares tumbled more than 17% since it hit the all-time high of $148 a share at the beginning of the year.
Its share price has been under pressure over the …
Aurora Cannabis Enters Agreement With Heinrich Klenk GmbH & Co.
Vancouver-based Aurora Cannabis (TSX:ACB) has entered into an agreement, through its subsidiary Pedanios, with one of Europe’s largest medicinal plant company Heinrich Klenk GmbH & Co. KG.
Heinrich Klenk, whose products are available …
Novartis Lawyer Leaves Company Due to Michael Cohen Payment
In a statement released on Wednesday, Swiss drug manufacturing company Novartis AG (NYSE:NVS) announced that one of its lawyers will be leaving the company due to the companies recent agreement with Michael D. Cohen —US …
AveXis Inc to be Acquired by Novartis AG – Shares Skyrocket
Shares of the gene therapy company, AveXis Inc. (Nasdaq:AVXS) skyrocketed after it was announced today that the company would be bought Novartis AG (NYSE:NVS), a drug manufacturing company.
According to the press release, …
Clovis Oncology Gets FDA Approval for Ovarian Cancer Treatment
Colorado-based biopharmaceutical company, Clovis Oncology (Nasdaq:CLVS) has received approval from the United States Food and Drug Administration (FDA) today for the company’s ovarian cancer maintenance treatment, RUBRACA (rucaparib).
RUBRACA, which is available in …
Incyte Corporation Stock Takes a Nose Dive After Drug Trial Failure
Stock of the biotechnology company Incyte Corporation (Nasdaq:INCY) have taken a nosedive today after the company released the failed results of their cancer research Phase 3 ECHO-301/KEYNOTE-252 study.
>>>Auris Health – Monarch Platform …
Opioids Prescribed Less in States where Medical Marijuana is Legal
Two studies, from the University of Georgia and the University of Kentucky, found that in states where medical marijuana is legal, there was a smaller prescription rate of opioids.
The study from the …
Auris Health – Monarch Platform Will Revolutionize Medical Intervention
Silicon Valley-based Auris Health Inc., formerly Auris Surgical Robotics Inc., announced that the company’s Monarch Platform has received clearance from the US Food and Drug Administration.
The platform received clearance for diagnostic and …